A

AbCellera Biologics
D

ABCL

2.03000
USD
-0.06
(-2.64%)
مفتوح الان
حجم التداول
1,620
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
621,304,290
أصول ذات صلة
AMAT
AMAT
-12.230
(-8.28%)
135.480 USD
AMD
AMD
-9.180
(-8.91%)
93.810 USD
AVGO
AVGO
-6.300
(-4.09%)
154.070 USD
INTC
INTC
0.460
(2.09%)
22.440 USD
MRVL
MRVL
-7.540
(-11.93%)
55.680 USD
MU
MU
-14.260
(-16.10%)
74.330 USD
NVDA
NVDA
-8.470
(-7.68%)
101.840 USD
QCOM
QCOM
-14.680
(-9.52%)
139.470 USD
SWKS
SWKS
-8.020
(-12.38%)
56.760 USD
TSM
TSM
-6.885
(-4.37%)
157.400 USD
المزيد
الأخبار المقالات

العنوان: AbCellera Biologics

القطاع: Healthcare
الصناعة: Biotechnology
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.